https://www.tga.gov.au/scheduling-decision-final/notice-final-decisions-amend-or-not-amend-current-poisons-standard-relation-psilocybin-and-mdma
The decision is in, the TGA won’t (at this stage) down schedule these substances.
I feel the reasoning provided is sound, and the TGA has essentially indicated they are awaiting further phase 3 results.
note - this doesn’t at all impact the ability of Emyria to keep researching these drugs! Nor does it impact their cannabinoid work (promising bioavailability data out today in a separate announcement!).
if there’s a dip, I’ll be buying it.
TGA decides not to downschedule psilocybin/MDMA
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.001(2.00%) |
Mkt cap ! $17.96M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.9¢ | $11.57K | 236.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 86047 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 105964 | 2 |
View Market Depth
| Last trade - 10.17am 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.9¢ |
Change
-0.001 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.9¢ | 4.9¢ | 4.9¢ | 66100 | ||
| Last updated 11.19am 08/05/2024 ? | |||||
| EMD (ASX) Chart |